Guinea-Castanares J, Iturralde-Iriso J, Campo-Cimarras E, Elizondo-Pinillos I, Martínez-Iniesta G

Language: Spanish
References: 20
Page: 127-132
PDF size: 183.64 Kb.

ABSTRACT

Objective: To describe the outcomes in the rural and urban populations who participated in the Colorectal Cancer (CRC) program in the province of Álava, Autonomous Community of the Basque Country, Spain, between 2008 and 2022. Methods: A retrospective, cross-sectional, descriptive observational study was carried out. The Boston Standardized and Validated Scale was used. Participants underwent a well-prepared, complete colonoscopy. They were also assigned the most severe histological lesion found. Findings were classified as: normal, low-risk adenoma, medium- risk adenoma, high-risk adenoma, carcinoma (CRC), relevant non-neoplastic pathology, and inconclusive (positive iBT without definitive diagnosis). Results: During the CRC screening rounds from 2009 to 2022, individual invitations were sent to each household, and a total of 395,926 were valid. The participation rate for the iTTD test, except for the first year in 2009, was 58.98%; the remaining years ranged from 67.14% to 74.43%. Conclusions: The CCR screening program is a screening method that is really effective, so we consider that it is necessary to promote this method well so that the population has an increasing participation, placing special emphasis on health areas where they are in situations with greater difficulty in accessing the health system.

REFERENCES

1. Marzo-Castillejo M, Bartolomé-Moreno C, Bellas-BeceiroB, Melús-Palazón E, Vela-Vallespín C. Cancer PreventionRecomendations. PAPPS 2022 update. AtenPrimaria. 1 de octubre de 2022;54:102440.

2. Jodal HC, Helsingen LM, Anderson JC, Lytvyn L, VandvikPO, Emilsson L. Colorectal cancer screening with faecaltesting, sigmoidoscopy or colonoscopy: a systematicreview and network meta-analysis. BMJ Open. 1 deoctubre de 2019;9(10):e032773.

3. Lopez de Munain A, Audicana C. Health Departmentof the Basque Goverment. Cancer in the AutonomousCommunity of Euskadi [Internet]. 2023. [Access August2024] Available at: https://www.euskadi.eus/informacion/registros-de-cancer/web01-a3regepi/es

4. Arana-Arri E, Idigoras I, Uranga B, Pérez R, Irurzun A,Gutiérrez-Ibarluzea I, et al. Population-based colorectalcancer screening programmes using a faecal immunochemicaltest: should faecal haemoglobin cut-offsdiffer by age and sex? BMC Cancer. 29 de agosto de2017;17(1):577.

5. Idigoras I, Arrospide A, Portillo I, Arana-Arri E, Martínez-Indart L, Mar J, et al. Evaluation of the colorectalcancer screening Programme in the Basque Country(Spain) and its effectiveness based on the Miscan-colon model. BMC Public Health. 1 de agosto de2017;18(1):78.

6. Unanue-Arza S, Idigoras-Rubio I, Fernández-LandaMJ, Bilbao-Iturribarria I, Bujanda L, Portillo I. Analysisof Post-Colonoscopy Colorectal Cancer and Its Subtypesin a Screening Programme. Cancers. enero de2021;13(20):5105.

7. Arrospide A, Idigoras I, Mar J, De Koning H, Van derMeulen M, Soto-Gordoa M, et al. Cost-effectivenessand budget impact analyses of a colorectal cancerscreening programme in a high adenoma prevalencescenario using MISCAN-Colon microsimulation model.BMC Cancer. 25 de abril de 2018;18(1):464.

8. Pereiro Sánchez E, Díaz Grávalos GJ, Gándara QuintasCM, Varela Estévez MJ, Del Álamo Alonso AJ, CasadoGórriz I. Delayed diagnosis in colorectal cancer basedon background. Rev Clínica Med Fam. 2012; 5(3):176–81.

9. López-Torres-Hidalgo J, Simarro-Herráez MJ, Rabanales-Sotos J, Campos-Rosa R, de-la-Ossa-Sendra B,Carrasco-Ortiz C. The attitudes of primary care providerstowards screening for colorectal cancer. Rev EspEnfermedades Dig. 2013; 105 (5): 272–278.

10. Syriopoulou E, Morris E, Finan PJ, Lambert PC, RutherfordMJ. Understanding the impact of socioeconomicdifferences in colorectal cancer survival: potentialgain in life-years. British Journal of Cancer. 2019; 120:1052–1058.

11. Anthes LE, Hajizadeh M. Socioeconomic inequalities inpancreatic cancer incidence in Canada: evidence fromCancer Registry data. J Public Health. 2020;30:801-10.

12. Provincial institute of social Welfare. Demographicsand population [Internet]. Vitoria: Provincial instituteof social Welfare. 2023. [Access August 2024].Available at: https://www.dataraba.eus/es/indicadores/ver/estructura-de-la-poblacion-por-sexo-grupos-de-edad-y-ambito-territorial-2006-2023/in-131/

13. Osakidetza CRC screening program coordination center.Colorectal cancer screening program [Internet].2022. [Access August 2024]. Available at: https://www.osakidetza.euskadi.eus/enfermedad-cancer/-/programa-cribado-cancer-colorrecta

14. Calderwood AH, Jacobson BC. Comprehensive Validationof the Boston Bowel Preparation Scale. GastrointestEndosc. octubre de 2010;72(4):686-92.

15. Edge SB, Compton CC. The American Joint Committeeon Cancer: the 7th edition of the AJCC cancer stagingmanual and the future of TNM. Ann Surg Oncol. juniode 2010;17(6):1471-4

16. Mosquera I Mendizabal N, Martín U, Martín U, et al.Inequalities in participation in colorectal cancer screeningprogrammes: a systematic review. Revista Europeade Salud Pública. 2020; 30 (3):416–425.

17. Valiente-Gonzalez, Escribano-Sotos, De Miguel-IbańezR. Colorectal Cancer Screening in Castilla La Mancha,Spain: The Influence of Social, Economic, Demographicand Geographic Factors. J Community Health.2022; 47(3): 446–53.

18. Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, MeesterRG, Barzi A, et al. Colorectal cancer statistics, 2017. CACancer J Clin . 2017; 67 :177–93.

19. Hall IJ, Tangka FK, Sabatino SA, Thompson TD, GraubardBI, Breen N. Patterns and Trends in Cancer Screeningin the United States. Prev Chronic Dis. 2018; 15:97.

20. Jackson CS, Oman M, Patel AM, Vega KJ. Health disparitiesin colorectal cancer among racial and ethnicminorities in the United States. J Gastrointest Oncol .2016; 7 ( Suppl 1 ):S32–S43.